quality_control_of_tablets_lecture_1.ppt
- 2. Quality Control (Q.C.) Definition: Quality control is concerned with sampling, specifications for raw material, and finished product, testing, documentation, release product, analytical methodologies and good laboratory practice.
- 3. Quality control tests of tablets Specifications for tablets: 1. The tablet should include the correct dose of the drug (Weight uniformity and content uniformity test). 2. The drug should be released from the tablet in a controlled and reproducible way (Dissolution test). 3. The tablet should show sufficient mechanical strength to withstand fracture and erosion during manufacturing and handling (Hardness and friability test). 4. The appearance of the tablet should be elegant and its weight, size and appearance should be consistent (Visual observation, weight variation, thickness and diameter of the tablet). 5. The tablet should be packed in a safe manner.
- 4. Official Quality control tests for tablets (Compendial tests) British Pharmacopoeia (B.P.) & US Pharmacopoeia (USP) 1- Uniformity of content of active ingredient (Uniformity of weight & Content uniformity) 2- Disintegration test. 3- Dissolution test. 4- Friability test. There are many tests that frequently applied to tablets for which there are non-pharmacopoeial requirements but will form a part of manufacture's owner product specifications. 1- Tablet thickness. 2- Tablet hardness. Non-Compandial tests
- 5. I. Official standards (Q. C. tests) for tablets (Compendial tests) Uniformity of active ingredient: To ensure a constant dose of drug between individual tablets. Traditionally, dose variation between tablets is tested in two separate tests; 1- Weight uniformity 2- Content uniformity If the drug forms greater part of the tablet ( more than ≥25 mg and ≥25%), any variation in the tablet weight obviously indicates a variation in the active ingredient. (Weight uniformity test) If the drug is potent (USP specifies less than < 25 mg of the active ingredient, or comprising < 25% by weight of unit), the excipients form the greater part of the tablet weight and the correlation between the tablet weight and amount of the active ingredient can be poor, in this case another test (Content uniformity) must be performed.
- 6. 1. Weight uniformity (weight variation) - Weigh 20 tablets individually (i.e. determine the weight of each tablet alone; X1, X2, X3… X20) - Calculate the average weight of tablets ( = Total weight of tablets ) Number of tablets Average weight of tablets (X) = (X1+X2 +X3+…+ X20)/20 Percentage deviation Average tablet weight (X) Pharmaceutical form 10 7.5 5 80 mg or less >80 - < 250 mg 250 mg or more Tablets
- 8. 1. The size & distribution of the granules being compressed (presence of too large or too fine granules). 2. Poor flow and high speed turret speed (incomplete filling of die),. 3. Poor mixing. (Sometimes the lubricants & glidants have not been well distributed). 4. When lower punches are of unequal lengths, the fill of each die varies because the fill is volumetric 5. Demixing or segregation of powder constituents of different crystalinity, size and densities; in direct compression. Causes of weight variation
- 9. 2. Content uniformity USP defines content uniformity test for tablets containing less than < 25 mg or less than < 25% drug substance in case of coated or uncoated tablets. ● Determining the amount of drug in a sample of tablets (10 ). ● The average drug content is calculated. ● The content of the individual tablets should fall within specified limits in terms of % deviation from the mean (85 – 115%). If not comply, repeat using 20 more tablets. No one should be 75 – 125% deviation. If content uniformity test is required, the weight uniformity test is not required.
- 10. Disintegration All tablets must pass a test for disintegration except Chewable tablets and some Extended release tablets. The test is carried out by: • Agitating a given number of tablets in an aqueous medium (Water or simulated gastric/ intestinal fluid ) at a defined temperature (37 ± 2 °C) & the time to reach the end-point of the test is recorded.
- 11. The disintegration apparatus Six tubes opened at the upper end and closed by a screen at the lower A cylindrical disk of transparent plastic is also used if specified in monograph.
- 12. The end point of the test (i.e. complete disintegration) is achieved when no tablet fragments remain on the screen (fragments of coating may remain). The preparation complies with the test if the time to reach this end-point is below given limit; < 30 minutes for uncoated immediate release tablets. but varying from 2 min for nitroglycerin sublingual tablets to up to 4 hrs for buccal tablets. If one or two tablets failed to disintegrate, repeat test on 12 additional tablets: at least 16 of the 18 (6 + 12) tested tablets should pass the test.
- 13. Special cases • Effervescent tablets • Place 1 tablet in a beaker containing 200 ml of water at (15-25°C; the tablet should evolve bubbles and when the evolution of gas around the tablet stops, the tablet has disintegrated. The same procedures are performed for other 5 tablets. The tablets comply with the test if each of the six tablets used disintegrated within 5 min or as justified. Disintegration beaker Effervescent tablets
- 14. • Soluble tablets • Soluble tablets disintegrate within 3 min when placed in water at 25°C. ● Disintegration test for enteric coated tablets: Enteric coated tablets are similarly tested except that the tablets are tested first in the simulated gastric fluid (0.1N HCl) for specific time (2hr in B.P. and 1 hr in USP) for a positive test, after which no signs of disintegration, cracking or softening must be seen, followed by immersion in stimulated intestinal fluid (Phosphate buffer pH 6.8) for the time stated in the individual monograph, during which time the tablets disintegrate completely. Enteric coated tablets